AndrewLeoSochackiMD

PubMed

• 190 citations
  Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock.
  Julia V. Busik, Maria Tikhonenko, Ashay D Bhatwadekar, Madalina Opreanu, Nafissa Yakubova
  The Journal of Experimental Medicine. 2009-12-21
• 74 citations
  The Unconventional Role of Acid Sphingomyelinase in Regulation of Retinal Microangiopathy in Diabetic Human and Animal Models
  Madalina Opreanu, Maria Tikhonenko, Svetlana N. Bozack, Todd A. Lydic, Gavin E. Reid
  Diabetes. 2011-09-01
• 66 citations
  N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function.
  Maria Tikhonenko, Todd A. Lydic, Madalina Opreanu, Sergio Li Calzi, Svetlana N. Bozack
  Plos One. 2013-01-29

Journal Articles

• Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)  
  Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood

Abstracts/Posters

• Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...
  Andrew Sochacki, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Next generation myelofibrosis risk analysis in the electronic health record.
  Andrew L. Sochacki, Cosmin Adrian Bejan, Shilin Zhao, Travis Spaulding, Thomas Stricker, Yaomin Xu, Michael R. Savona, American Society of Hematology Annual Meeting, San Diego, California, 12/2018
• Identification of myelofibrosis from electronic health records with novel algorithms and JAKextractor.
  Cosmin Adrian Bejan, Andrew Sochacki, Shilin Zhao, Yaomin Xu, Michael Savona, Proceedings of the Annual Meeting of the American Association for Cancer Research, Chicago, Illinois, 4/2018
• Preliminary Results from a Phase I Dose Escalation Trial of Ruxolitinib and the PI3Kδ Inhibitor TGR-1202 in Myelofibrosis.
  Tamara K Moyo*, Andrew Sochacki*, Gregory D Ayers, Michael T. Byrne, Stephen A. Strickland, Sanjay R. Mohan, Jill Harrison, Lynne D Berry, Channing V Dudley, Rachel Se..., American Society of Hematology Annual Meeting, San Diego, California, 12/2017
• Join now to see all

Lectures

• Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019